Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
Sobi’s Sanofi-partnered Altuvoct (efanesoctocog alfa) has been recommended by the National Institute for Health and Care ...
Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...
CLEVELAND, Ohio — Eggs are disappearing from store shelves due to shortages caused by the avian flu outbreak, but never fear — the eggs used to make the flu vaccine are safe.
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...
10hon MSN
California’s low-cost insulin plan is more than a year behind schedule with no clear timeline. Advocates say the delay is ...
Hosted on MSN18h
Novel Berberine Drug Cut HbA1c in Type 2 DiabetesMore participants in the higher-dose group than placebo achieved an HbA1c under 7% (55.9% vs 15.2%) or under 6.5% (29.4% vs 6 ...
Valbiotis unveils its annual financial statements and confirms its strategic and financial goals VALBIOTIS SA VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms ...
Following the Food and Drug Administration’s approval of Lutathera and Pluvicto in 2018 and 2022, respectively, we predicted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback